Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carl Dambkowski currently holds 116,483 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl Dambkowski has been a net seller of APGE stock. They have purchased $0 and sold $3.1M worth of shares.
Carl Dambkowski's most recent insider trade was on Jan 23, 2026, when they sold 116,483 shares at $0.00 per share.
Carl Dambkowski serves as Executive at Apogee Therapeutics, Inc. (APGE). They have executed 25 insider transactions totaling $3.1M over their tenure at the company.
Carl Dambkowski holds the position of Executive at Apogee Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Carl Dambkowski has shown a selling trading pattern, with $0 in total purchases and $3.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carl Dambkowski was on Dec 4, 2025, when they sold $817.5K worth of APGE shares. This transaction involved 10,900 shares at $75.00 per share.
Carl Dambkowski currently owns 116,483 shares of Apogee Therapeutics, Inc. (APGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carl Dambkowski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carl Dambkowski has 25 Form 4 filings on record as an insider at Apogee Therapeutics, Inc..
Set alerts for Carl Dambkowski and 40,000+ other insiders.